|Articles|April 8, 2008

India Converts Failing Vaccine Plants to Testing Labs

The Indian government has reacted to the enforced closure of three of its oldest vaccine manufacturing plants by launching a plan to convert them to drug testing laboratories.

INDIA-April 8. 2008-Nick Taylor reports for LabTechnologist.com that the BCG Vaccine Laboratory, Pasteur Institute of India and the Central Research Institute were shut down in January after failing to comply with current good manufacturing practices (cGMP). However, they will now receive a new lease of life testing the safety and efficacy of drugs and vaccines produced and sold within the country or exported. In addition to this they will be responsible for detecting counterfeit and spurious batches of drugs. To read more, click here: www.labtechnologist.com//news/ng.asp?n=84492&c=8YMEJy20NE7MmUMHbx1tWw%3D%3D.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!